– Balixafortide(POL 6326) is a  novel potent, selective, peptidic CXCR4 antagonist that interferes with the tumor-protective microenvironment and sensitizes tumor cells to chemotherapy.								
				 
		
				
				
									– C[C@@H]1NN[C@@H](CC2NC=NC=2)C(=O)N[C@@H](CC2C=CC(O)=CC=2)C(=O)N2[C@@H](CCC2)C(=O)N2[C@H](CCC2)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC2C=CC(O)=CC=2)C(=O)N[C@@H]2C(N[C@@H](CC3C=CC(O)=CC=3)C(C([C@H](CCCNC(N)=N)NC([C@H](CCN)NC([C@@H]3N(C([C@H](C)NC([C@H](CO)NC(=O)[C@H](CSSC2)NC1=O)=O)=O)CCC3)=O)=O)=O)=O)=O